Krka's Q3 Sales Top EUR 270m

Novo Mesto, 28 November - Slovenia's leading drug maker, Krka, has increased sales revenues by nine percent in the first nine months of the year, to SIT 63.9bn (EUR 270.5m). While sales increased on all of Krka's main markets, Western Europe showed the best performance, as revenues were up by 84 percent, the company said Friday.